financetom
Business
financetom
/
Business
/
Update: Market Chatter: Amazon Joins Microsoft in Legislation to Curb Nvidia's Exports to China
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Amazon Joins Microsoft in Legislation to Curb Nvidia's Exports to China
Nov 14, 2025 7:24 AM

09:54 AM EST, 11/14/2025 (MT Newswires) -- (Updates with Amazon ( AMZN ) response in the eighth paragraph.)

Amazon.com ( AMZN ) is joining Microsoft ( MSFT ) in supporting legislation to further mitigate Nvidia's ( NVDA ) ability to export to China, The Wall Street Journal reported late Thursday, citing unnamed congressional aides and sources familiar with the matter.

Microsoft ( MSFT ) is publicly supporting the Gain AI Act legislation, while officials at Amazon's ( AMZN ) cloud unit have informed Senate members they also support the legislation, the report said, citing the sources.

Chip companies would have to fulfill US demand before exporting products to China and other regions subject to arms embargoes, according to the WSJ. The legislation would provide tech firms including Microsoft ( MSFT ) and Amazon ( AMZN ) preferential access to chips at their data centers globally.

Alphabet's (GOOG, GOOGL) Google and Meta Platforms (META) have taken no stance yet and neither has President Trump, the people told the news outlet.

Artificial intelligence model developer Anthropic is also supporting Amazon ( AMZN ) and Microsoft ( MSFT ) in this stance, the WSJ said, citing the people.

An Nvidia ( NVDA ) spokesperson told MT Newswires in an email Friday that the company does not "sell restricted products to adversaries at the expense" of US companies and sales to authorized clients globally do not "deprive" American customers of anything.

"The pundits feeding fake news to Congress about chip supply would overturn President Trump's AI Action Plan and surrender America's chance to lead in AI and computing worldwide," the spokesperson said.

An Amazon ( AMZN ) spokesperson told MT Newswires the company has no comment while Microsoft ( MSFT ) did not immediately respond to a request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 235.39, Change: -2.19, Percent Change: -0.92

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Burford Capital's Q4 Swings to a Loss; Revenue Falls
Burford Capital's Q4 Swings to a Loss; Revenue Falls
Mar 3, 2025
08:46 AM EST, 03/03/2025 (MT Newswires) -- Burford Capital ( BUR ) reported a Q4 loss Monday of $0.06 per diluted share, swinging from earnings of $0.45 a year earlier. Two analysts polled by FactSet expected $0.54. Revenue for the quarter ended Dec. 31 was $93 million, down from $292.6 million a year earlier. Three analysts polled by FactSet expected...
Ares Management Finalizes Acquisition of GCP International
Ares Management Finalizes Acquisition of GCP International
Mar 3, 2025
08:37 AM EST, 03/03/2025 (MT Newswires) -- Ares Management Corporation ( ARES ) said Monday it completed its acquisition of GCP International, not including its operations in greater China. The acquisition increases Ares' total managed assets to over $525 billion, including more than $115 billion in its Real Assets division as of Dec. 31, the company said. Ares said the...
UBS Comments on Mexico's Peso Ahead of Tuesday's U.S. Tariffs Deadline
UBS Comments on Mexico's Peso Ahead of Tuesday's U.S. Tariffs Deadline
Mar 3, 2025
08:45 AM EST, 03/03/2025 (MT Newswires) -- A month has passed since United States President Donald Trump first threatened and then delayed a 25% tariff on Mexican goods, noted UBS. This Tuesday, these are set to go into effect. The Mexican peso, which has trended broadly sideways since rump's election, may face renewed pressure, wrote the bank in a note...
Lexicon Says Pilavapadin Showed 'Meaningful' Pain Reduction But Results Miss Primary Endpoint
Lexicon Says Pilavapadin Showed 'Meaningful' Pain Reduction But Results Miss Primary Endpoint
Mar 3, 2025
08:40 AM EST, 03/03/2025 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) said Monday a phase 2b study evaluating pilavapadin for diabetic peripheral neuropathic pain demonstrated that the oral, non-opioid achieved meaningful pain reduction versus placebo and was well-tolerated in the 10 mg dose. The company said, however, that the study results did not reach statistical significance on the primary...
Copyright 2023-2026 - www.financetom.com All Rights Reserved